Lebanese Center for Energy Conservation (LCEC) and the Lebanese Republic Ministry of Energy and Water (MEW):
The Second National Renewable Energy Action Plan for the Republic of Lebanon
[…]Multiple myeloma is a debilitating disease with an incurable nature, yet the past few years have seen the emergence of many novel agents with proven efficacy and improved tolerability.[…]
Ibrutinib Monotherapy Moderately Effective in Relapsing or Refractory Follicular Lymphoma (FL)
Ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, showed modest efficacy in relapsing or rituximab-refractory follicular lymphoma (FL).
Atopic dermatitis (AD) affects more than 4% of adults and 10% of children, making it the most common chronic inflammatory skin disease. A recent longitudinal study found that childhood AD symptoms persisted well into adolescence and longer, suggesting that AD may persist more commonly than previously recognized. Furthermore, AD poses a significant economic concern and a substantial burden on physical and emotional health and social wellbeing.